Timothy J. Bettington - Mar 1, 2024 Form 4 Insider Report for Elanco Animal Health Inc (ELAN)

Role
Executive Vice President, Corporate Strategy and Market Development
Signature
/s/ Amy C. Seidel, as Attorney-in-Fact for Timothy J. Bettington
Stock symbol
ELAN
Transactions as of
Mar 1, 2024
Transactions value $
$0
Form type
4
Date filed
3/5/2024, 04:30 PM
Previous filing
Apr 5, 2023
Next filing
Apr 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELAN Common Stock Award $0 +21.8K +20.2% $0.00 130K Mar 1, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELAN Employee Stock Option(right to buy) Award $0 +47.6K $0.00 47.6K Mar 1, 2024 Common Stock 47.6K $16.03 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of restricted stock units pursuant to the Amended and Restated 2018 Elanco Stock Plan on March 1, 2024, one-third vesting on March 1, 2025, one-third vesting on March 1, 2026, and the remaining vesting on March 1, 2027.
F2 Grant of stock options vesting as follows: one-third vesting on March 1, 2025, one-third vesting on March 1, 2026, and the remaining vesting on March 1, 2027.

Remarks:

Executive Vice President, Corporate Strategy and Market Development